5:51 PM
 | 
Mar 02, 2010
 |  BC Extra  |  Company News

Shionogi in-licenses QuatRx's ospemifene

QuatRx Pharmaceuticals Co. (Ann Arbor, Mich.) granted Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507) exclusive, worldwide rights to develop and commercialize ospemifene....

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >